CD44 and neoplasm: They prevent the association of MMP9 with its receptors (α4β1 integrin/CD44), resulting in the blocking of a downstream signalling pathway required for MMP9-mediated tumour cell migration in vitro and the inhibition of tumour metastasis in xenograft mouse models of lung cancer [213,214].